Jeffrey Leiden, Executive Chairman of Vertex, has expressed their delight in having Michel Lagarde join the Vertex Board and said his experience and track record will be valuable for the growth and expansion of the pharmaceutical business.
Vertex has announced plans for recent expansion to support the company's recent growth and further research into cell and genetic therapy. Vertex has also dedicated a site to Jeffrey Leiden, called the Jeffrey Leiden Center for Cell and Genetic Therapies I.